(2S)-2-((Tetrahydro-2H-pyran-2-yl)oxy)propan-1-ol → 6-((S)-2-Hydroxy-propoxy)-imidazo[1,2-b]pyridazine-2-carboxylic acid [5-(3-chloro-4-trifluoromethyl-phenyl)-1H-benzoimidazol-2-yl]-amide
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:12]2[CH:33]=[CH:32][C:15]3[NH:16][C:17]([NH:19][C:20]([C:22]4[N:23]=[C:24]5[CH:29]=[CH:28][C:27](Cl)=[N:26][N:25]5[CH:31]=4)=[O:21])=[N:18][C:14]=3[CH:13]=2)[CH:5]=[CH:6][C:7]=1[C:8]([F:11])([F:10])[F:9].O1CCCCC1[O:40][C@@H:41]([CH3:44])[CH2:42][OH:43]>>[Cl:1][C:2]1[CH:3]=[C:4]([C:12]2[CH:33]=[CH:32][C:15]3[NH:16][C:17]([NH:19][C:20]([C:22]4[N:23]=[C:24]5[CH:29]=[CH:28][C:27]([O:43][CH2:42][C@@H:41]([OH:40])[CH3:44])=[N:26][N:25]5[CH:31]=4)=[O:21])=[N:18][C:14]=3[CH:13]=2)[CH:5]=[CH:6][C:7]=1[C:8]([F:9])([F:11])[F:10]Participants
3
Reactant 2
Product 1
Procedure
6-((S)-2-Hydroxy-propoxy)-imidazo[1,2-b]pyridazine-2-carboxylic acid [5-(3-chloro-4-trifluoromethyl-phenyl)-1H-benzoimidazol-2-yl]-amide (38 mg) was prepared from 6-chloro-imidazo[1,2-b]pyridazine-2-carboxylic acid [5-(3-chloro-4-trifluoromethyl-phenyl)-1H-benzoimidazol-2-yl]-amide (80 mg) and (S)-2-(tetrahydro-pyran-2-yloxy)-propan-1-ol (100 μL) as described above in Example 122. LCMS (m/z): 532. 1H NMR (400 MHz, DMSO-d6): δ 12.5 and 11.5 (1H, brs) 8.85 (1H, s) 8.14 (1H, d) 8.02 (1H, brs) 7.85-7.93 (3H, m) 7.55-7.63 (2H, m) 7.07 (1H, d) 5.01 (1H, d) 4.17 (2H, d) 4.02-4.07 (1H, m) 1.19 (3H, d).
Sources & evidence
- ORD record
- ord-17b1dd4c6c5d4ee7922adf10823ccd45
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450354B2
Reaction notes
Loading…